Cor Vasa 2006, 48(10):340-344 | DOI: 10.33678/cor.2006.111

Serum cystatin C as a long-term predictor of overall mortality.

David Stejskal1,2,*, Bořek Lačňák2, Pavlína Solichová2, Libor Jedelský2, František Všianský3, Božena Hausnerová1, Michal Karpíšek4
1 Interní oddělení
2 Oddělení laboratorní medicíny, Nemocnice Šternberk p. o., Šternberk
3 Ústav klinické biochemie, Fakultní nemocnice Ostrava-Poruba, Ostrava
4 Veterinární a farmakologická fakulta, Brno, Česká republika

Background:
Renal disorders with impaired renal functions are considered a significant risk factor for increased mortality.

Methods:
In a cross-sectional retrospective study, a total of 974 individuals (506 men, 468 women) were examined and their serum creatinine and cystatin C levels were analyzed in 1997. Follow-up was 8 years with death as the end point.

Results:
Serum cystatin C values did not differ between men and women (medians 1.28 vs. 1.27 mg/l; p = 0.9). Serum cystatin C values correlated with age (r = 0.37; p < 0.01). Two hundred and sixty subjects died during follow-up. The median
cystatin C level was significantly higher in the deceased (1.54 vs. 1.21; p < 0.01). The relative risk of death of individuals in the lowest cystatin C quartile was 12% while that of individuals in the highest cystatin C quartile was 48%. The odds ratio between the lowest and highest quartiles (1 vs. 4) was 6.9. Even when adjusted for age, cystatin C levels were significantly higher in the deceased (medians: 0.0114 vs. 0.0089; p < 0.01).

Conclusion:
Individuals with increased serum cystatin C levels have been at increased risk of death over 8-year follow-up.

Keywords: Cystatin C; Mortality; Creatinine

Published: October 1, 2006  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Stejskal D, Lačňák B, Solichová P, Jedelský L, Všianský F, Hausnerová B, Karpíšek M. Serum cystatin C as a long-term predictor of overall mortality. Cor Vasa. 2006;48(10):340-344. doi: 10.33678/cor.2006.111.
Download citation

References

  1. Shlipak MG, Wassel Fyr CL, Chertow GM, et al. Cystatin C and mortality risk in the elderly: the health, aging, and body composition study. J Am Soc Nephrol 2006;17:254-61. Go to original source... Go to PubMed...
  2. Fried LF, Katz R, Sarnak MJ, et al. Kidney function as a predictor of noncardiovascular mortality. J Am Soc Nephrol 2005;16:3728-35. Go to original source... Go to PubMed...
  3. Larsson A, Helmersson J, Hansson LO, Basu S. Increased serum cystatin C is associated with increased mortality in elderly men. Scand J Clin Lab Invest 2005; 65:301-5. Go to original source... Go to PubMed...
  4. Ahlstrom A, Tallgren M, Peltonen S, Pettila V. Evolution and predictive power of serum cystatin C in acute renal failure. Clin Nephrol 2004;62:344-50. Go to original source... Go to PubMed...
  5. Jernberg T, Lindahl B, James S, et al. Cystatin C. A novel predictor of outcome in suspected or confirmed non-ST-elevation acute coronary syndrome. Circulation 2004;19:2342-8. Go to original source... Go to PubMed...
  6. Shlipak MG, Katz R, Fried LF, et al. Cystatin-C and mortality in elderly persons with heart failure. J Am Coll Cardiol 2005;18:268-71. Go to original source... Go to PubMed...
  7. Sarnak MJ, Katz R, Stehman-Breen CO, et al. Cardiovascular Health Study. Cystatin C concentration as a risk factor for heart failure in older adults. Ann Intern Med 2005;142:497-505. Go to original source... Go to PubMed...
  8. Grubb AO. Cystatin C - properties and use as diagnostic marker. Adv Clin Chem 2000;35: 63-9. Go to original source... Go to PubMed...
  9. Saleem M, Florkowski CM, George PM, Woltersdorf WW. Comparison of two prediction equations with radionuclide glomerular filtration rate: validation in routine use. Ann Clin Biochem 2006;43:309-13. Go to original source... Go to PubMed...
  10. Kuan Y, Hossain M, Surman J, El Nahas AM, Haylor J. GFR prediction using the MDRD and Cockcroft and Gault equations in patients with end-stage renal disease. Nephrol Dial Transplant 2005;20:2394-401. Go to original source... Go to PubMed...
  11. Schannwell CM. Cardiac alterations caused by renal failure. Med Klin 2006;22 (Suppl I):69-71.
  12. Brunini TM, da Silva CD, Siqueira MA, Moss MB, Santos SF, Mendes-Ribeiro AC. Uremia, atherothrombosis and malnutrition: the role of L-arginine-nitric oxide pathway. Cardiovasc Hematol Disord Drug Targets 2006; 6:133-40. Go to original source... Go to PubMed...
  13. Kalousova M, Zima T, Tesar V, Dusilova-Sulkova S, Skrha J. Advanced glycoxidation end products in chronic diseases-clinical chemistry and genetic background. Mutat Res 2005;579:37-46. Go to original source... Go to PubMed...




Cor et Vasa

You are accessing a site intended for medical professionals, not the lay public. The site may also contain information that is intended only for persons authorized to prescribe and dispense medicinal products for human use.

I therefore confirm that I am a healthcare professional under Act 40/1995 Coll. as amended by later regulations and that I have read the definition of a healthcare professional.